Yeadon is a big pharma veteran with 32 years in the industry. He worked as the head of allergy and respiratory research at Pfizer from 1995 to 2011 and is the former founder and CEO of Ziarco, a biotech company acquired by Novartis. Furthermore, he has a doctorate in respiratory pharmacology and holds a Double First Class Honors degree in biochemistry and toxicology.
"The worst flu season over the last decade is worse than [the threat] posed by this new virus," Yeadon told The Epoch Times via email.
Yeadon said that being sure the vaccines would cause no harm in the long run should have been imperative.
"It’s simply not possible to obtain data demonstrating adequate longitudinal safety in the time period any pandemic can last. Those who pushed this line of argument and enabled the gene-based agents to be injected needlessly into billions of innocent people are guilty of crimes against humanity."
Yeadon feels that the novel vaccines should have not been given emergency use authorization (EUA) and that if he were directing the pandemic response, children, pregnant women, and people who already had contracted the virus would have been given a red light on the jabs.
"I would have outright denied their use in children, in pregnancy, and in the infected/recovered. Point blank. I’d need years of safe use before contemplating an alteration of this stance."
He further argues that the vaccines were sure to be toxic and it was only a matter of degree of toxicity.
"Having selected spike protein to be expressed, a protein which causes blood clotting to be initiated, a risk of thromboembolic adverse events was burned into the design. Nothing at all limits the amount of spike protein to be made in response to a given dose. Some individuals make a little and only briefly. The other end of a normal range results in synthesis of copious amounts of spike protein for a prolonged period. The locations in which this pathological event occurred, as well as where on the spectrum, in my view played a pivotal role in whether the victim experienced adverse events including death," Yeadon said.
"There are many other pathologies flowing from the design of these agents, including for the mRNA 'vaccines' that lipid nanoparticle formulations leave the injection site and home to liver and ovaries, among other organs, but this evidence is enough to get started."
“From data that we have, there appears to be a concentration of the lipid nanoparticles, which are very, very small particles, which are in the vaccine that are injected into the arm,” Dr. James Thorp told The Epoch Times, “and then the vast majority of those are dispersed throughout the entire body.”
A lipid nanoparticle is a fat-soluble membrane that is the cargo of the messenger RNA.
“They appear to concentrate in the ovaries, and they appear to cross all God-made barriers in the human body, the blood-brain barrier, the placental barrier during pregnancy, into the fetal bloodstream, and all the fetal tissues inside the womb, crossing the blood-brain barrier in the fetus, the baby in the womb, which is very concerning,” he noted, since the eggs produced by women are limited in number, and they would be “exposed to a potentially disastrous toxic lipid nanoparticle.”
Another concern that Yeadon had not noticed during his initial study was that “the mRNA products (Pfizer & Moderna) would accumulate in ovaries.”
“An FOI request to the Japanese Medicines Agency revealed that product accumulation in ovaries occurred in experiments in rodents," Yeadon said. "I searched the literature based on these specific concerns and found a 2012 review, explicitly drawing attention to the evidence that the lipid nanoparticle formulations as a class do, in fact, accumulate in ovaries and may represent an unappreciated reproductive risk to humans. This was ‘a well known problem’ to experts in that field.”
Referring to the study, Yeadon told The Epoch Times that “the authors tell untruths. They say something like ‘there was no increase in anti-syncytin-1 antibodies.'”
“No, that’s wrong. Their data is clearly 2.5X increased after vaccination and obviously statistically significant (functional significance is looking confirmed by the miscarriage rate),” Yeadon noted.
“What they’ve done is cute. They’ve chosen a completely arbitrary level they scribed on the figure below which they claim nothing matters. No evidence whatsoever for that claim. In fact, in the discussion, they confess we don’t know the relationship between antibodies and the impact on function.”
Yeadon believes that the pharmaceutical industry “definitely knew,” since 2012, that the lipid nanoparticles would accumulate in the ovaries of women that took the vaccines.
“No one in the industry or in leading media could claim ‘they didn’t know about these risks to successful pregnancy.'”